The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma without overexpression of HER2 receptors.
 
Sebastian Ochenduszko
Honoraria - Roche/Genentech; Teva
Research Funding - Roche/Genentech; Sandoz
Travel, Accommodations, Expenses - Janssen Oncology; Roche/Genentech
 
Kamil Konopka
Honoraria - Medac
Research Funding - PPD; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Pfizer; Teva
 
Miroslawa Puskulluoglu
Research Funding - Roche/Genentech; Sandoz
 
Katarzyna Urbanczyk
No Relationships to Disclose
 
Andrzej Budzynski
No Relationships to Disclose
 
Maciej Matlok
No Relationships to Disclose
 
Agata Lazar
No Relationships to Disclose
 
Anna Sinczak-Kuta
No Relationships to Disclose
 
Krzysztof Krzemieniecki
No Relationships to Disclose